AAAAAA
Results: 201-225/396
Authors:
DALGLEISH A
Citation: A. Dalgleish, THE CASE FOR THERAPEUTIC VACCINES, Melanoma research, 6(1), 1996, pp. 5-10
Authors:
MAEURER MJ
STORKUS WJ
KIRKWOOD JM
LOTZE MT
Citation: Mj. Maeurer et al., NEW TREATMENT OPTIONS FOR PATIENTS WITH MELANOMA - REVIEW OF MELANOMA-DERIVED T-CELL EPITOPE-BASED PEPTIDE VACCINES, Melanoma research, 6(1), 1996, pp. 11-24
Authors:
OHASHI A
FUNASAKA Y
UEDA M
ICHIHASHI M
Citation: A. Ohashi et al., C-KIT RECEPTOR EXPRESSION IN CUTANEOUS MALIGNANT-MELANOMA AND BENIGN MELANOCYTIC NEVI, Melanoma research, 6(1), 1996, pp. 25-30
Authors:
DANEN EHJ
TENBERGE PJM
VANMUIJEN GNP
JAGER MJ
RUITER DJ
Citation: Ehj. Danen et al., EXPRESSION OF CD44 AND THE PATTERN OF CD44 ALTERNATIVE SPLICING IN UVEAL MELANOMA, Melanoma research, 6(1), 1996, pp. 31-35
Authors:
STEINBECK RG
HESELMEYER KM
GERLACH B
BJORNHAGEN V
AUER GU
Citation: Rg. Steinbeck et al., DIAGNOSTIC IMPACT OF NUCLEAR-DNA CONTENT AND PROLIFERATIVE ACTIVITY IN BENIGN AND MALIGNANT MELANOCYTIC LESIONS, Melanoma research, 6(1), 1996, pp. 37-43
Authors:
CURRY BJ
SMITH MJ
HERSEY P
Citation: Bj. Curry et al., DETECTION AND QUANTITATION OF MELANOMA-CELLS IN THE CIRCULATION OF PATIENTS, Melanoma research, 6(1), 1996, pp. 45-54
Authors:
MENZIES SW
INGVAR C
MCCARTHY WH
Citation: Sw. Menzies et al., A SENSITIVITY AND SPECIFICITY ANALYSIS OF THE SURFACE MICROSCOPY FEATURES OF INVASIVE MELANOMA, Melanoma research, 6(1), 1996, pp. 55-62
Authors:
CLEMENTE C
BELLI F
MASCHERONI L
BUFALINO R
RAO S
BALDINI MT
MIHM MC
CASCINELLI N
Citation: C. Clemente et al., BIOLOGICAL-ACTIVITY AND CLINICAL EFFICACY OF INTRAVENOUS HIGH-DOSE THYMOPENTIN IN METASTATIC MELANOMA PATIENTS, Melanoma research, 6(1), 1996, pp. 63-69
Authors:
MACKENZIE H
RETSAS S
Citation: H. Mackenzie et S. Retsas, MALIGNANT-MELANOMA COEXISTING WITH SARCOIDOSIS - IMPLICATIONS FOR PROGNOSIS AND MANAGEMENT, Melanoma research, 6(1), 1996, pp. 71-72
Authors:
HUNT G
TODD C
THODY AJ
Citation: G. Hunt et al., UNRESPONSIVENESS OF HUMAN EPIDERMAL MELANOCYTES TO MSH - ASSOCIATION WITH RED HAIR (VOL 5, PG 38, 1995), Melanoma research, 6(1), 1996, pp. 74-74
Authors:
SPARROW LE
ENGLISH DR
HEENAN PJ
DAWKINS HJS
TARAN J
Citation: Le. Sparrow et al., PROGNOSTIC-SIGNIFICANCE OF P53 OVEREXPRESSION IN THIN MELANOMAS, Melanoma research, 5(6), 1995, pp. 387-392
LIGHT AND ELECTRON-MICROSCOPIC FINDINGS ON EXPERIMENTAL MELANOMAS AFTER HYPERTHERMIA AT 50-DEGREES-C
Authors:
JOURNEEDEKORVER JG
OOSTERHUIS JA
VRENSEN GFJM
Citation: Jg. Journeedekorver et al., LIGHT AND ELECTRON-MICROSCOPIC FINDINGS ON EXPERIMENTAL MELANOMAS AFTER HYPERTHERMIA AT 50-DEGREES-C, Melanoma research, 5(6), 1995, pp. 393-402
Authors:
KUPSCH JM
TIDMAN N
BISHOP JAN
MCKAY I
LEIGH I
CROWE JS
Citation: Jm. Kupsch et al., GENERATION AND SELECTION OF MONOCLONAL-ANTIBODIES, SINGLE-CHAIN FV AND ANTIBODY FUSION PHAGE SPECIFIC FOR HUMAN MELANOMA-ASSOCIATED ANTIGENS, Melanoma research, 5(6), 1995, pp. 403-411
Authors:
LUCCHINA LC
BARNHILL RL
DUKE DM
SOBER AJ
Citation: Lc. Lucchina et al., FAMILIAL CUTANEOUS MELANOMA, Melanoma research, 5(6), 1995, pp. 413-418
Authors:
RIXE O
BOREL C
PARAISO D
BENHAMMOUDA A
PETIT T
ANTOINE E
BIZZARI JP
AUCLERC G
SOUBRANE C
WELL M
GIROUX B
BANZET P
KHAYAT D
Citation: O. Rixe et al., FOTEMUSTINE, DACARBAZINE, VINDESINE COMBINATION CHEMOTHERAPY IN ADVANCED MALIGNANT-MELANOMA - A PHASE-II STUDY OF 43 PATIENTS, Melanoma research, 5(6), 1995, pp. 419-424
Authors:
VROUENRAETS BC
KROON BBR
KLAASE JM
NIEWEG OE
VANSLOOTEN GW
VANDONGEN JA
Citation: Bc. Vrouenraets et al., SEVERE ACUTE REGIONAL TOXICITY AFTER NORMOTHERMIC OR MILD HYPERTHERMIC ISOLATED LIMB PERFUSION WITH MELPHALAN FOR MELANOMA, Melanoma research, 5(6), 1995, pp. 425-431
Authors:
GILES G
STAPLES M
MCCREDIE M
COATES M
Citation: G. Giles et al., MULTIPLE PRIMARY MELANOMAS - AN ANALYSIS OF CANCER REGISTRY DATA FROMVICTORIA AND NEW-SOUTH-WALES, Melanoma research, 5(6), 1995, pp. 433-438
Authors:
RETSAS S
Citation: S. Retsas, 1ST INTERNATIONAL-CONFERENCE ON THE ADJUVANT THERAPY OF MALIGNANT-MELANOMA - LONDON, UK, 24-25 MARCH 1995, Melanoma research, 5(6), 1995, pp. 439-440
Citation: ABSTRACTS OF THE 1ST INTERNATIONAL-CONFERENCE ON THE ADJUVANT THERAPYOF MALIGNANT-MELANOMA - LONDON, UK, 24-25 MARCH 1995, Melanoma research, 5(6), 1995, pp. 441-449
Authors:
PARMIANI G
COLOMBO MP
Citation: G. Parmiani et Mp. Colombo, SOMATIC GENE-THERAPY OF HUMAN-MELANOMA - PRECLINICAL STUDIES AND EARLY CLINICAL-TRIALS, Melanoma research, 5(5), 1995, pp. 295-301
Authors:
LUO D
CHEN H
SEARLES G
JIMBOW K
Citation: D. Luo et al., COORDINATED MESSENGER-RNA EXPRESSION OF C-KIT WITH TYROSINASE AND TRP-1 IN MELANIN PIGMENTATION OF NORMAL AND MALIGNANT HUMAN MELANOCYTES AND TRANSIENT ACTIVATION OF TYROSINASE BY KIT SCF-R/, Melanoma research, 5(5), 1995, pp. 303-309
Authors:
HOFMANNWELLENHOF R
FINKPUCHES R
SMOLLE J
HELIGE C
TRITTHART HA
KERL H
Citation: R. Hofmannwellenhof et al., CORRELATION OF MELANOMA CELL MOTILITY AND INVASION IN-VITRO, Melanoma research, 5(5), 1995, pp. 311-319
Authors:
CHELVI PT
JAIN SK
RALHAN R
Citation: Pt. Chelvi et al., HEAT-MEDIATED SELECTIVE DELIVERY OF LIPOSOME-ASSOCIATED MELPHALAN IN MURINE MELANOMA, Melanoma research, 5(5), 1995, pp. 321-326
Authors:
BIJWAARD K
HEARING VJ
SONTHEIMER R
LIEU TS
VIEIRA WD
GERSTEN DM
Citation: K. Bijwaard et al., STUDIES ON THE EXPRESSION AND IMMUNOGENICITY OF THE B50 MELANOMA ANTIGEN AND ITS RELATIONSHIP WITH CALRETICULIN, Melanoma research, 5(5), 1995, pp. 327-336
Authors:
BAHARAV E
MERIMSKY O
ALTOMONTE M
SHOENFELD Y
PAVLOVIC M
MAIO M
FERRONE S
FISHMAN P
Citation: E. Baharav et al., ANTI-TYROSINASE ANTIBODIES PARTICIPATE IN THE IMMUNE-RESPONSE TO VACCINATION WITH ANTIIDIOTYPIC ANTIBODIES MIMICKING THE HIGH-MOLECULAR-WEIGHT MELANOMA-ASSOCIATED ANTIGEN, Melanoma research, 5(5), 1995, pp. 337-343